Invention Grant
- Patent Title: Methods of treating obsessive compulsive disorder (OCD) or anxiety using an antibody that binds to annexin-1
-
Application No.: US14365311Application Date: 2012-12-14
-
Publication No.: US10752677B2Publication Date: 2020-08-25
- Inventor: Fulvio D'Acquisto , Mauro Perretti
- Applicant: Queen Mary & Westfield College, Univ. of London
- Applicant Address: GB London
- Assignee: Queen Mary & Westfield College, University of London
- Current Assignee: Queen Mary & Westfield College, University of London
- Current Assignee Address: GB London
- Agency: Stradley Ronon Stevens & Young, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@75dd85d7
- International Application: PCT/GB2012/000906 WO 20121214
- International Announcement: WO2013/088111 WO 20130620
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; A61K39/00
Abstract:
The present invention provides a specific binding molecule that binds to Annexin-1 (Anx-A1) for use in the treatment of obsessive compulsive disorder (OCD) or a disease related to OCD. The invention also provides a pharmaceutical composition comprising a specific binding molecule of the invention for use in the treatment of obsessive compulsive disorder (OCD) or a disease related to OCD.
Public/Granted literature
- US20150004164A1 Use Of Antibody Public/Granted day:2015-01-01
Information query
